Will Van Derveer

Myq Kaplan, stand-up comedian and philosopher exploring his own anxiety. Dr. Will Van Derveer, veteran psychiatrist and author specializing in psychedelic therapy. They discuss using ketamine, psilocybin, and MDMA to loosen rigid brain patterns. They compare rapid ketamine effects with psilocybin’s promise, weigh risks and preparation, and stress therapy and integration over casual use.

Keith Kurlander, MA, LPC, a counselor who blends integrative psychotherapy and peak-potential coaching, and Will Van Derveer, MD, a researcher and psychiatrist focused on psychedelic-assisted therapy, discuss trauma, the Enneagram, and limits of talk therapy. They explore how psychedelics like ketamine and MDMA can access nonverbal trauma, the vital role of integration, ethical risks, and practical clinical models.

Will Van Derveer, psychiatrist and author known for work on psychedelic therapy, and Krista Van Derveer, relational leadership educator who helps partnerships shift to a We operating system. They explore crafting sacred relationship agreements, the surprising somatic "Couch Time" cooling technique, the Abundant Repair protocol to end tension, and how to see your partner with fresh eyes to protect connection.

Dr. Will Van Derveer, a leading psychiatrist and psychedelic therapy researcher, shares fascinating insights into the transformative power of MDMA in trauma recovery. He reveals shocking statistics, such as an 83% recovery rate for treatment-resistant PTSD, and discusses the importance of well-trained therapists to prevent harm. Listeners learn how MDMA enhances emotional connections and self-compassion, while contrasting its effectiveness against traditional SSRIs. The conversation also highlights the need for mindful approaches in psychedelic therapy, emphasizing love and connection as key ingredients in healing.

Dr. Will Van Derveer, a leading integrative psychiatrist, dives into the transformative world of psychedelic-assisted therapies. He shares his disillusionment with traditional mental health treatments and highlights the remarkable efficacy of ketamine, MDMA, and psilocybin for PTSD and depression. Van Derveer discusses the importance of 'set and setting' in therapy and the promising FDA decision on MDMA's rescheduling. This candid conversation opens new avenues for hope in mental health care, providing insights into a revolutionary approach.